Anatomy, Head and Neck, Nasopharynx (2024)

Introduction

The nasopharynx represents the most superior portion of the pharynx, bounded superiorly by the skull base and inferiorly by the soft palate. The nasopharynx connects the nasal cavity to the oropharynx and contains the Eustachian tube openings and adenoids. Notable clinical situations include nasopharyngeal carcinoma and adenoidal hypertrophy. This review will discuss the anatomy of the nasopharynx, including the structure, function, embryology, blood supply, innervation, anatomical variants, and clinical relevance.

Structure and Function

Boundaries of the nasopharynx[1][2]:

  • Superiorly: the skull base.

  • Anteriorly: the nasal cavity.

  • Posteriorly: posterior pharyngeal wall.

  • Inferiorly: the soft palate.

  • Laterally: the medial pterygoid plates and superior pharyngeal constrictor muscles (surrounded by visceral fascia)

Shape and Size[2]:

The anterior-posterior (A-P) diameter of the nasopharynx is approximately 2 cm, and the height is approximately 4 cm.

Contents[1][2][3]:

  • The eustachian tube opening is located at the posterolateral wall.

  • The torus tubarius is located immediately posterior to the opening of the eustachian tube.

  • The fossa of Rosenmuller is located superior and posteriorly to the torus tubarius.

  • The adenoids (nasopharyngeal tonsils) are located in the roof and posterior wall of the nasopharynx.

Function[4][2][5][6]:

Embryology

As the name suggests, scientists believe that the nasopharynx derives from both the nasal cavity and the pharynx embryologically. Both the eustachian tube and its opening develop from the first pharyngeal arch. Therefore, posterior to the eustachian tube opening appears to be an embryological extension of the pharynx. Anterior to the eustachian tube opening is considered an extension of the nasal cavity via the primitive nasal sac. This theory has support from histological evidence that nasopharyngeal mucosa anterior to the eustachian tube opening resembles that of the nasal cavity (highly vascular and dense with lymphoid tissue) and posterior mucosa resembles that of the oropharynx (stratified squamous).[7]

The nasopharyngeal area derives from the neural crests of the ectodermal leaflet.

Blood Supply and Lymphatics

Vascular supply to the nasopharynx is provided by branches of the internal carotid artery (mandibular artery), maxillary artery (pterygopalatine artery), facial artery (ascending palatine artery), and ascending pharyngeal artery (superior pharyngeal artery). Venous drainage is via the parapharyngeal venous plexus. The plexus drains into the retropharyngeal and facial veins, which both drain to the internal jugular vein.[8][1]

Lymphatic drainage of the nasopharynx is particularly clinically relevant for patients with nasopharyngeal carcinoma. The initial lymph collecting system is a capillary network within the mucosal membrane, which is connected to a similar network within the nasal atrium, turbinates, and posterior floor. From there, the first-tier lymph nodes are the retropharyngeal, referred to as the Rouvière nodes. The retropharyngeal nodes lead to the internal jugular nodes.[9][1]

Nerves

Sensory innervation anterior to the eustachian tube opening is via the maxillarydivisionof the trigeminal nerve (CN V2), which travels through the sphenopalatine ganglion. The glossopharyngeal nerve (CN IX) provides posterior sensory innervation. Muscles originating in the nasopharynx receive their motor supply from the vagus nerve (CN X), except for the tensor veli palatini muscle, which is supplied by the mandibulardivisionof the trigeminal nerve (CN V3).[7][10][6]

Muscles

The primary muscles associated with the nasopharynx are the tensor veli palatini, levator veli palatini, and the salpingopharyngeus, which all originate from the eustachian tube opening. The tensor veli palatini tenses the soft palate, and the levator veli palatini elevates the soft palate, which helps seal off the nasopharynx from the oropharynx during swallowing. The salpingopharyngeus also aids with swallowing by elevating the pharynx. Additionally, all three of these muscles open the eustachian tube orifice during swallowing, which helps equilibrate atmospheric pressure between the middle ear cavity and the nasopharynx.[2][6]

Physiologic Variants

The dimensions of the nasopharynx (height and A-P diameter) vary significantly between individuals. Additionally, asymmetry of the superficial landmarks, such as the eustachian tube openings, describes the major physiologic (anatomic) variants of the nasopharynx. When asymmetry is observed on endoscopic or radiologic imaging, infiltrating tumors or mucosal masses versus benign anatomic variants should merit consideration. Lateral recesses, such as the fossa of Rosenmuller, become more visible with aging, which appears to be a consequence of physiologic degeneration of submucosal lymphoid tissue (adenoids).[11]

Surgical Considerations

Adenoidectomy

Adenoidectomy, the removal of adenoid tissue, is amongst the most common surgeries performed by an otolaryngologist. The adenoids (nasopharyngeal tonsils) are within the roof and posterior wall of the nasopharynx. Nasopharyngeal adenoid hypertrophy (NAH) is a common cause of nasal obstruction and sleep-disordered breathing (SDB)/obstructive sleep apnea (OSA) in children, and it is associated with recurrent otitis media and chronic rhinosinusitis. There are three primary indications for an adenoidectomy: chronic otitis media with effusion and concomitant eustachian tube dysfunction, recurrent rhinosinusitis refractory to standard medical treatment, andaccompanying tonsillectomy for management of SDB/OSA. Adenoid tissue can regenerate post-removal but rarely to the extent to reproduce pre-operative symptoms.[12][3][13]

The traditional method of removing adenoid tissue is using the “blind curettage” method. With this method, the adenoid tissue is not directly visible; therefore, there is a theoretical risk of leaving residual tissue. Consequently, endoscopic techniques have been developed to help achieve full visualization. The most popular endoscopic techniques use a “microdebrider” or radiofrequency.[14]

Clinical Significance

Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor that most commonly originates from the fossa of Rosenmuller. Southern Chinese males (40to 60 years old) have the highest incidence. Predisposing factors appear to be host genetics (HLA gene on chromosome 6p21), environmental factors (i.e., chemicals or carcinogens), and Epstein-Barr Virus (EBV) infection. Due to the association with EBV, antibody titers are useful diagnostic markers. The size of the tumor is the crucial prognostic factor, and radiation therapy is the treatment of choice.[1][15]

Regarding nodal metastasis, cervical lymphadenopathy is the most common presenting symptom (75% of cases). Typically, the retropharyngeal nodes are the first to be involved; however, in 35% of cases, the retropharyngeal nodes are bypassed, and the internal jugular nodes are the first to be involved. Nodal metastasis exhibits an inferior spread pattern; thus, superior nodes will be larger than inferior nodes. Distant metastasis appears to occur at higher rates in NPC in comparison to other head and neck cancers (5 to 41% vs. 5 to 24%). Bone and lungs are the most common sites of distant metastasis.[1]

A nonspecific symptom of NPC is a headache; however, NPCs can spread to adjacent structures. Therefore, presenting signs and symptoms typically depend on which structures are involved. If the tumor involves the eustachian tube opening, the patient can present with serous otitis media, typically unilateral. Tumors can spread anteriorly through the sphenopalatine foramen and then the pterygopalatine fossa. From there, malignant cells can spread centrally along the CN V3 to enter the cranium. Lateral spread to the parapharyngeal space also puts CN V3 at risk, and denervation atrophy of the mastication muscles are visible on MRI in these scenarios. Trismus, also known as “lockjaw,” is a common presenting symptom if the medial or lateral pterygoid muscles are affected. Posterolateral spread into the carotid space puts CNs IX, X, XI, XII at risk; thus, symptoms associated with these nerves can be present. Posterior spread through the posterior pharyngeal wall and retropharyngeal space can infiltrate the prevertebral muscles. The involvement of the vertebral bodies and spinal cord occurs in late stages. Inferior spread into the oropharynx is most easily observable with MRI. Superior spread can lead to cranial involvement via the foramen lacerum, foramen ovale, or direct skull-base erosion. Spread in every direction can result in cavernous sinus involvement, which may present with CN III, IV, V1, and VI injuries.[1]

Nasopharyngeal Adenoid Hypertrophy

The adenoids, also known as the nasopharyngeal tonsils, are located in the roof and posterior wall of the nasopharynx and contribute to Waldeyer’s ring of lymphoid tissue. Normally, the adenoids undergo physiological hypertrophy at 6-10 years of age. Nasopharyngeal adenoid hypertrophy (NAH) refers to non-physiologic enlargement, typically benign, and it is the most common cause of nasal obstruction in children. The etiology of NAH is unknown, but persistent rhinitis may be a risk factor. Patients commonly present with open-mouth breathing, snoring, rhinorrhea, and obstructive sleep apnea (OSA). Treatment of choice is an adenoidectomy.[16][17][12]

NAH is not common in adulthood since the adenoids naturally regress, starting at approximately age 16. Theoretical etiologies of adult NAH may be persistent NAH from childhood, re-proliferation in response to infection, or a response to an infection in an immunocompromised state.[12]

Granulomatosis with Polyangiitis

Granulomatosis with polyangiitis (GPA), formerly called Wegner’s granulomatosis, is an idiopathic small-to-medium-sized vessel vasculitis. Classically, GPA involves the nasopharynx, lungs, and kidneys. In 80% of patients, the initial presenting symptoms involve the nasopharynx, which can include uncomplicated sinusitis, nosebleeds, and damage to the bony walls of the sinus. When a patient is only presenting with nasopharyngeal symptoms, it is referred to as “limited GPA,” and 46 to 70% of these patients are positive for c-ANCA. Mainstay treatment is immunosuppression with cyclophosphamide and corticosteroids, and up to 90% of patients improve with this regiment. Rituximab is also available for refractory cases.[18]

Nasopharyngeal Cyst

Nasopharyngeal cysts are rare and usually present asymptomatically; therefore, most are diagnosed incidentally on imaging or routine nasal endoscopy. However, these cysts may present with cerebral spinal fluid (CSF) rhinorrhea, purulent rhinorrhea, nasal obstruction, headache, and middle ear effusion. CSF rhinorrhea is associated with a congenital defect of the craniopharyngeal canal. Normally, this canal degenerates in the 6th week of gestation after the formation of the anterior pituitary gland from Rathke’s pouch. If the craniopharyngeal canal remains patent (0.42% of the asymptomatic population), ventral nasopharyngeal cysts may form and lead to CSF rhinorrhea. Treatment for symptomatic cysts is surgical resection.[19]

Juvenile Nasopharyngeal Angiofibroma

Juvenile nasopharyngeal angiofibroma (JNA) is a benign, vascular tumor that typically occurs in young males 9-19 years of age. JNAs are rare, representing 0.05% of all head and neck tumors. Common symptoms include nasal obstruction and epistaxis, and treatment of choice is surgical resection with preoperative embolization. Without treatment, aggressive JNAs can spread to adjacent structures leading to worsening nasal obstruction, severe and recurrent epistaxis, facial pain, and visual changes.[20][21]

Nasopharyngeal Swab

Nasopharyngeal swabs are routinely performed to test for several viral and bacterial pathogens, including adenovirus, coronavirus (multiple strains), human metapneumovirus, influenza (A and B), parainfluenza, rhinovirus, RSV (A and B), Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. More recently, nasopharyngeal swabs have been the collection method of choice to confirm infection with the novel coronavirus disease 2019 (COVID-19).[22][23]

Other Issues

Post adenoidectomy can lead to the formation of scar tissue, which in the long run could cause a narrowing of the airways. This event could occur, in particular, if muscle tissue or soft tissue suffered partial damage during the surgical approach.[24]

The nasopharyngeal area is the site of investigation for the presence of COVID-19, through the use of a swab.The operator inserts the swab into the nose, and following an imaginary line on a horizontal plane, between the nostril and the ear, collects material.[25]

References

1.

Chong VF, Ong CK. Nasopharyngeal carcinoma. Eur J Radiol. 2008 Jun;66(3):437-47. [PubMed: 18485650]

2.

Mukherji SK, Castillo M. Normal cross-sectional anatomy of the nasopharynx, oropharynx, and oral cavity. Neuroimaging Clin N Am. 1998 Feb;8(1):211-8. [PubMed: 9449761]

3.

Ramos SD, Mukerji S, Pine HS. Tonsillectomy and adenoidectomy. Pediatr Clin North Am. 2013 Aug;60(4):793-807. [PubMed: 23905820]

4.

Pohunek P. Development, structure and function of the upper airways. Paediatr Respir Rev. 2004 Mar;5(1):2-8. [PubMed: 15222948]

5.

McLaughlin KE, Jacobs IN, Todd NW, Gussack GS, Carlson G. Management of nasopharyngeal and oropharyngeal stenosis in children. Laryngoscope. 1997 Oct;107(10):1322-31. [PubMed: 9331307]

6.

Shaw SM, Martino R. The normal swallow: muscular and neurophysiological control. Otolaryngol Clin North Am. 2013 Dec;46(6):937-56. [PubMed: 24262952]

7.

Tobias PV. The nasopharynx: review of structure and development, with notes on speech, pharyngeal hypophysis, chordoma and the dens. J Dent Assoc S Afr. 1981 Nov;36(11):765-78. [PubMed: 6952607]

8.

Davis KR. Embolization of epistaxis and juvenile nasopharyngeal angiofibromas. AJR Am J Roentgenol. 1987 Jan;148(1):209-18. [PubMed: 3024474]

9.

Pan WR, Suami H, Corlett RJ, Ashton MW. Lymphatic drainage of the nasal fossae and nasopharynx: preliminary anatomical and radiological study with clinical implications. Head Neck. 2009 Jan;31(1):52-7. [PubMed: 18972423]

10.

Kanagasuntheram R, Wong WC, Chan HL. Some observations on the innervation of the human nasopharynx. J Anat. 1969 Mar;104(Pt 2):361-76. [PMC free article: PMC1232009] [PubMed: 5765756]

11.

Mancuso AA, Bohman L, Hanafee W, Maxwell D. Computed tomography of the nasopharynx: normal and variants of normal. Radiology. 1980 Oct;137(1 Pt 1):113-21. [PubMed: 7422832]

12.

Yildirim N, Sahan M, Karslioğlu Y. Adenoid hypertrophy in adults: clinical and morphological characteristics. J Int Med Res. 2008 Jan-Feb;36(1):157-62. [PubMed: 18304415]

13.

Buchinsky FJ, Lowry MA, Isaacson G. Do adenoids regrow after excision? Otolaryngol Head Neck Surg. 2000 Nov;123(5):576-81. [PubMed: 11077344]

14.

Ferreira MS, Mangussi-Gomes J, Ximendes R, Evangelista AR, Miranda EL, Garcia LB, Stamm AC. Comparison of three different adenoidectomy techniques in children - has the conventional technique been surpassed? Int J Pediatr Otorhinolaryngol. 2018 Jan;104:145-149. [PubMed: 29287856]

15.

Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019 Jul 06;394(10192):64-80. [PubMed: 31178151]

16.

Surov A, Ryl I, Bartel-Friedrich S, Wienke A, Kösling S. MRI of nasopharyngeal adenoid hypertrophy. Neuroradiol J. 2016 Oct;29(5):408-12. [PMC free article: PMC5033103] [PubMed: 27531860]

17.

Huang SW, Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2001 Oct;87(4):350-5. [PubMed: 11686429]

18.

von Itzstein MS, Abeykoon JP, Summerfield DD, Whitaker JA. Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis. BMJ Case Rep. 2017 Jul 19;2017 [PMC free article: PMC5534968] [PubMed: 28724596]

19.

Marom T, Russo E, Ben Salem D, Roth Y. Nasopharyngeal cysts. Int J Pediatr Otorhinolaryngol. 2009 Aug;73(8):1063-70. [PubMed: 19211159]

20.

Leong SC. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope. 2013 May;123(5):1125-31. [PubMed: 23553370]

21.

Yu J, Choi JS, Giannoni C, Patel AJ, Gallagher KK. Juvenile Nasopharyngeal Angiofibroma Outcomes and Cost: Analysis of the Kids' Inpatient Database. Ann Otol Rhinol Laryngol. 2020 May;129(5):498-504. [PubMed: 31876164]

22.

Leber AL, Lisby JG, Hansen G, Relich RF, Schneider UV, Granato P, Young S, Pareja J, Hannet I. Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens. J Clin Microbiol. 2020 Apr 23;58(5) [PMC free article: PMC7180242] [PubMed: 32132186]

23.

Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020 Dec;9(1):747-756. [PMC free article: PMC7172701] [PubMed: 32196430]

24.

Kim BY, Lim JH, Lee S, Hwang Y. 3D-structural change of nasopharynx following adenoidectomy: 10-year serial data in a single hospital. Eur Arch Otorhinolaryngol. 2020 May;277(5):1391-1395. [PubMed: 32052143]

25.

Petruzzi G, De Virgilio A, Pichi B, Mazzola F, Zocchi J, Mercante G, Spriano G, Pellini R. COVID-19: Nasal and oropharyngeal swab. Head Neck. 2020 Jun;42(6):1303-1304. [PMC free article: PMC7267300] [PubMed: 32352180]

Anatomy, Head and Neck, Nasopharynx (2024)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Horacio Brakus JD

Last Updated:

Views: 5897

Rating: 4 / 5 (71 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Horacio Brakus JD

Birthday: 1999-08-21

Address: Apt. 524 43384 Minnie Prairie, South Edda, MA 62804

Phone: +5931039998219

Job: Sales Strategist

Hobby: Sculling, Kitesurfing, Orienteering, Painting, Computer programming, Creative writing, Scuba diving

Introduction: My name is Horacio Brakus JD, I am a lively, splendid, jolly, vivacious, vast, cheerful, agreeable person who loves writing and wants to share my knowledge and understanding with you.